ESTA (Establishment Labs Holdings) Days Payable: 220.87 (As of Mar. 2026) — 52% Above Median


ESTA Establishment Labs Holdings Inc ESTA
75 GF Score
Price $85.81
GF Value $61.35
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Establishment Labs Holdings Days Payable?

Establishment Labs Holdings ESTA -1.86% 75 Days Payable is 220.87 as of Mar. 2026, which is 52% above its 10-year median of 145.35. GuruFocus rates ESTA with a GF Score™ of 75/100 and a GF Value™ of $61.35 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Establishment Labs Holdings ranks better than 86.29% on this metric.

Establishment Labs Holdings's average Accounts Payable for the three months ended in Mar. 2026 was $42.5 Mil. Establishment Labs Holdings's Cost of Goods Sold for the three months ended in Mar. 2026 was $17.5 Mil. Hence, Establishment Labs Holdings's Days Payable for the three months ended in Mar. 2026 was 220.87.

The historical rank and industry rank for Establishment Labs Holdings's Days Payable or its related term are showing as below:

ESTA' s Days Payable Range Over the Past 10 Years
Min: 87.32   Med: 145.35   Max: 279.03
Current: 239.61

During the past 10 years, Establishment Labs Holdings's highest Days Payable was 279.03. The lowest was 87.32. And the median was 145.35.

ESTA's Days Payable is ranked better than
86.29% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 68.07 vs ESTA: 239.61

Establishment Labs Holdings's Days Payable declined from Mar. 2025 (302.45) to Mar. 2026 (220.87). It may suggest that Establishment Labs Holdings accelerated paying its suppliers.


Establishment Labs Holdings Days Payable Historical Data

* Premium members only.

The historical data trend for Establishment Labs Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Establishment Labs Holdings Days Payable Chart

Establishment Labs Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106.98 114.29 193.43 279.03 247.59

Establishment Labs Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 302.45 287.49 270.94 198.01 220.87

ESTA vs AXGN, TMDX, BFLY: Days Payable Comparison

For the Medical Devices subindustry, Establishment Labs Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Establishment Labs Holdings Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's Days Payable falls into.


ESTA
75GF Score
Establishment Labs Holdings Inc ESTA
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Establishment Labs Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Establishment Labs Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (44.76 + 43.109) / 2 ) / 64.768*365
=43.9345 / 64.768*365
=247.59

Establishment Labs Holdings's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (43.109 + 41.813) / 2 ) / 17.542*365 / 4
=42.461 / 17.542*365 / 4
=220.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 220.87 mean?
Establishment Labs Holdings (ESTA) has a Days Payable of 220.87 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Establishment Labs Holdings and its competitors. This is 52% above median its historical median of 145.35. Over the past decade, Establishment Labs Holdings' Days Payable has ranged from 87.32 to 279.03. According to the industry distribution chart, Establishment Labs Holdings ranks #109 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 13.7%.
Is Establishment Labs Holdings' Days Payable too high?
Establishment Labs Holdings' current Days Payable of 220.87 is 52% above median its 10-year median of 145.35. Over the past 10 years, this metric has ranged from a low of 87.32 to a high of 279.03. The Medical Devices & Instruments industry median Days Payable is 68.07. Establishment Labs Holdings' value of 220.87 is 224.5% above this industry median. Based on the distribution chart, Establishment Labs Holdings ranks #109 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Establishment Labs Holdings has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Establishment Labs Holdings' Days Payable compare to AXGN and TMDX?
According to the Medical Devices & Instruments industry distribution chart, Establishment Labs Holdings ranks #109 out of 795 companies for Days Payable. This places Establishment Labs Holdings in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Establishment Labs Holdings' value of 220.87 is 224.5% above this benchmark. Historically, Establishment Labs Holdings' own Days Payable has ranged from 87.32 to 279.03 over the past decade. While the company's 10-year median is 145.35 vs. the industry median of 68.07, Establishment Labs Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Establishment Labs Holdings's current Days Payable of 220.87 is 224.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Establishment Labs Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Establishment Labs Holdings's current Days Payable is 220.87, which is 52% above median its own 10-year median of 145.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Establishment Labs Holdings stock overvalued right now?
Based on GuruFocus' analysis, Establishment Labs Holdings (ESTA) is currently considered Significantly Overvalued. The stock's GF Value™ is $61.35, compared to a current price of $85.81 — trading 39.9% above its estimated fair value. The current Days Payable is 220.87, which is 52% above median its 10-year median of 145.35 and 224.5% above the Medical Devices & Instruments industry median of 68.07. Establishment Labs Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Establishment Labs Holdings (ESTA), the current Days Payable is 220.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Establishment Labs Holdings (ESTA) Overvalued in 2026?

Based on GuruFocus' analysis, Establishment Labs Holdings stock appears to be overvalued. The current stock price of $85.81 is trading 39.9% above its estimated GF Value™ of $61.35. GuruFocus considers Establishment Labs Holdings to be Significantly Overvalued.

Key valuation signals for ESTA:

  • Days Payable: 220.87 (52% above median its 10-year median of 145.35)
  • GF Value™: $61.35 vs. price of $85.81 (39.9% above fair value)
  • GF Score™: 75/100 with 5 warning signs
  • Industry Position: 224.5% above the Medical Devices & Instruments median (#109 of 795)

No single metric tells the full story. See the ESTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Establishment Labs Holdings Business Description

Other Exchanges 3E0:Germany
Address 11401 Century Oaks Terrace, Suite 400, Austin, TX, USA, 78758
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
75GF Score

Get the complete analysis for ESTA

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$85.81
Price
$61.35
GF Value